Business Context and Reporting Period
This Form 8-K is a current report filed by Neuralstem, Inc. (not Palisade Bio, Inc.) on December 29, 2009. The filing discloses a material event under Item 7.01 (Regulation FD Disclosure) regarding a completed private placement of common stock.
Key Financial Metrics
The filing details a capital raise event with the following metrics:
- Gross Proceeds: $1,500,000
- Shares Issued: 646,551 common shares
- Price Per Share: $2.32
- Investor Count: 1 accredited investor
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions outside of this specific transaction.
Material Changes
The primary material change is the increase in equity capital and outstanding share count resulting from the private placement completed on December 29, 2009. The company agreed to file a registration statement covering the resale of these shares by March 21, 2010.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors beyond the standard legal disclaimer stating that the information is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference except as expressly set forth.
Investor Verification Checklist
- Verify the correct registrant name is Neuralstem, Inc., as the input metadata referenced Palisade Bio, Inc.
- Confirm the impact of the 646,551 new shares on total outstanding shares and potential dilution.
- Check for the subsequent filing of the registration statement for resale by the March 21, 2010 deadline.
- Review the company's cash position post-transaction to assess runway for operations.